MedCity News October 11, 2024
Marissa Plescia

For 2025, the average star rating for Medicare Advantage Prescription Drug contracts was 3.92, compared to 4.07 for 2024, 4.14 for 2023 and 4.37 for 2022.

Average Medicare Advantage star ratings have declined once again, the Centers for Medicare and Medicaid Services (CMS) announced Thursday.

For 2025, the average star rating for Medicare Advantage Prescription Drug contracts was 3.92, compared to 4.07 for 2024, 4.14 for 2023 and 4.37 for 2022. Only seven contracts received a five-star rating for 2025, compared to 38 in 2024.

About 40% of Medicare Advantage Prescription Drug contracts that will be offered in 2025 received at least four stars. In addition, about 62% of Medicare Advantage Prescription Drug enrollees are currently in contracts with...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: CMS, Govt Agencies, Insurance, Medicare Advantage
Related Articles:
CMS ending VBID model due to high costs
CMS ends value-based Medicare Advantage model: 5 things to know
Trends 2025: Medicare Advantage prospects strong despite challenges
How the Federal Government Could Push People Toward Medicare Advantage – And Replace Traditional Medicare
The pros and cons of Medicare Advantage plans - 2

Share This Article